文献速递心律失常冠心病

冠状动脉旁路移植术后新发心房颤动的长期血栓栓塞风险

Long-term Thromboembolic Risk in Patients With Postoperative Atrial Fibrillation After Coronary Artery Bypass Graft Surgery and Patients With Nonvalvular Atrial Fibrillation.
PubMed 文献 · JAMA Cardiol · 2018-01-01

该队列研究比较了首次孤立冠状动脉旁路移植(CABG)术后新发术后心房颤动(POAF)患者与非手术非瓣膜性心房颤动(NVAF)患者的长期血栓栓塞风险。共匹配2108例POAF与8432例NVAF患者,POAF组血栓栓塞风险较低(HR 0.67,95%CI 0.55-0.81),且抗凝治疗与两组血栓栓塞风险降低相关。

要点

  • CABG术后新发POAF患者长期血栓栓塞风险低于NVAF患者。
  • POAF患者出院30天内口服抗凝启动率仅8.4%,远低于NVAF的42.9%。
  • 抗凝治疗与POAF和NVAF患者血栓栓塞风险降低均相关。

核心结论

  • CABG术后新发POAF的长期血栓栓塞风险低于非手术NVAF,不支持将新发POAF等同于原发性NVAF来评估长期血栓栓塞风险。

研究设计与样本

  • 基于临床心脏手术数据库和丹麦全国登记数据的队列研究,纳入2000年1月1日至2015年6月30日首次孤立CABG术后新发POAF患者,按年龄、性别、CHA2DS2-VASc评分和诊断年份以1:4比例匹配非手术NVAF患者。
  • 共纳入2108例POAF患者和8432例NVAF患者,中位年龄69.2岁(IQR 63.7-74.7),男性8675例(82.3%)。

主要发现

  • 出院后30天内启动口服抗凝治疗的比例:POAF组175例(8.4%),NVAF组3549例(42.9%)。

临床怎么用

  • CABG术后新发POAF患者应评估长期血栓栓塞风险,不应直接套用NVAF的抗凝策略。
  • 对于CABG术后新发POAF患者,可考虑个体化抗凝决策,需权衡血栓栓塞与出血风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: New-onset postoperative atrial fibrillation (POAF) is a common complication of coronary artery bypass graft (CABG) surgery. However, the long-term risk of thromboembolism in patients who develop POAF after CABG surgery remains unknown. In addition, information on stroke prophylaxis in this setting is lacking. OBJECTIVE: To examine stroke prophylaxis and the long-term risk of thromboembolism in patients with new-onset POAF after first-time isolated CABG surgery compared with patients with nonsurgical, nonvalvular atrial fibrillation (NVAF). DESIGN, SETTING, AND PARTICIPANTS: This cohort study used data from a clinical cardiac surgery database and Danish nationwide registries to identify patients undergoing first-time isolated CABG surgery who developed new-onset POAF from January 1, 2000, through June 30, 2015. These patients were matched by age, sex, CHA2DS2-VASc score, and year of diagnosis to patients with nonsurgical NVAF in a 1 to 4 ratio. Data analysis was completed from February 2017 to January 2018. MAIN OUTCOMES AND MEASURES: The proportion of patients initiating oral anticoagulation therapy within 30 days and the rates of thromboembolism. RESULTS: A total of 2108 patients who developed POAF after CABG surgery were matched with 8432 patients with NVAF. In the full population of 10 540 patients, the median (interquartile range) age was 69.2 (63.7-74.7) years; 8675 patients (82.3%) were men. Oral anticoagulation therapy was initiated within 30 days postdischarge in 175 patients with POAF (8.4%) and 3549 patients with NVAF (42.9%). The risk of thromboembolism was lower in the POAF group than in the NVAF group (18.3 vs 29.7 events per 1000 person-years; adjusted hazard ratio [HR], 0.67; 95% CI, 0.55-0.81; P < .001). Anticoagulation therapy during follow-up was associated with a lower risk of thromboembolic events in both patients with POAF (adjusted HR, 0.55; 95% CI, 0.32-0.95; P = .03) and NVAF (adjusted HR, 0.59; 95% CI, 0.51-0.68; P < .001) compared with patients who did not receive any anticoagulation therapy. Further, the risk of thromboembolism was not significantly higher in patients with POAF compared with those who did not develop POAF after CABG surgery (adjusted HR, 1.11; 95% CI, 0.94-1.32; P < .24). CONCLUSIONS AND RELEVANCE: New-onset POAF in patients who had undergone CABG surgery was associated with a lower long-term thromboembolic risk than that of patients who had NVAF. These data do not support the notion that new-onset POAF should be regarded as equivalent to primary NVAF in terms of long-term thromboembolic risk.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Butt JH, Xian Y, Peterson ED, et al. Long-term Thromboembolic Risk in Patients With Postoperative Atrial Fibrillation After Coronary Artery Bypass Graft Surgery and Patients With Nonvalvular Atrial Fibrillation. JAMA Cardiol. 2018. PMID: 29590304. doi:10.1001/jamacardio.2018.0405

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。